Low-income African-American high school students with asthma who participated in a specially designed, Web-based disease management program reported fewer days and nights with symptoms, fewer school days missed, fewer days of restricted activity, and less hospitalization for asthma during a 12-month follow-up period, as compared to nonparticipating asthmatic students.
The Howe School Alliance for Technology Management at Stevens Institute of Technology will host the lecture, “Enabling Technology: Changing the Management of Drug Safety and Pharmacovigilance,” on Thursday, May 3.
GlaxoSmithKline (GSK) and The Wellcome Trust today announced a collaboration to develop a new class of antibacterial to combat the rise of certain drug-resistant hospital-acquired infections, including those that lead to pneumonia.
The charity Asthma UK has issued advice for asthma sufferers following forecasts that summer 2007 is likely to be one of the hottest on record.
Adding a new dimension to its business, the Mukesh Ambani-led Reliance Life Sciences announced its partnership with US-based global investment management firm, MPM Capital LP.
The U.S. Food and Drug Administration (FDA) approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease (vWD).
On the occasion of the 2nd International Congress on Prediabetes and the Metabolic Syndrome held in Barcelona, Spain, April 25-28, 2007, the initiation of the Acarbose Cardiovascular Evaluation (ACE) was announced.
The American Gastroenterological Association (AGA) Institute is eager to increase the number of patients who receive screening for colon cancer. There are a variety of established screening methods that are widely available, and emerging technologies, such as computed tomography colonography (CT colonography), that are under investigation.
The larger — and busier — an NHS hospital is, the higher the MRSA infection rate, research from the Nottingham University Business School has revealed.
A report in the April 2007 issue of Psychiatric Services has identified a unique subgroup of schizophrenia patients in the United States who tend to receive depot antipsychotic medications.